Jiangsu Nhwa Pharmaceutical Co., LTD (002262.SZ) — Stock Score Summary

Jiangsu Nhwa Pharmaceutical Co., LTD (002262.SZ) has a MoatMap StockRank of 78/100 based on Quality (78/100), Value (43/100), and Momentum (40/100) factor scores. The current signal is BUY. Jiangsu Nhwa is a high-quality Chinese pharmaceutical company specializing in central nervous system (CNS) therapies (Q: 78). While it has strong domestic market share and high barriers to entry, it is primarily a drug developer rather than a pure-play global CDMO, limiting its exposure to our CDMO pricing power theme.

Jiangsu Nhwa Pharmaceutical Co., LTD develops and manufactures central nervous system (CNS) drugs, including anesthetics, analgesics, and psychotropics. It holds a dominant market share in China's highly regulated anesthetic and psychotropic drug segments, protected by strict state licensing. The company is a leading specialty pharmaceutical company with a powerful niche moat in CNS therapeutics.

Key Financial Metrics

Price$2.82
Market Cap$3.0B
P/E (TTM)18.25
P/E (Forward)12.99
Price/Book2.35
Return on Equity13.5%
Return on Invested Capital14.5%
Debt/Equity1.14
Gross Margin70.7%
Operating Margin21.3%
Revenue Growth6.6%
Dividend Yield2.1%
Free Cash Flow$6M

Jiangsu Nhwa Pharmaceutical Co., LTD operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Jiangsu Nhwa Pharmaceutical Co., LTD’s (002262.SZ) StockRank?
MoatMap’s StockRank for Jiangsu Nhwa Pharmaceutical Co., LTD (002262.SZ) is 78/100, with a Buy signal. It is a composite of Quality (78), Value (43), and Momentum (40) factor ranks across MoatMap’s 19,000+ stock universe.
Does Jiangsu Nhwa Pharmaceutical Co., LTD have an economic moat?
Jiangsu Nhwa Pharmaceutical Co., LTD (002262.SZ) has a Quality factor score of 78/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Jiangsu Nhwa Pharmaceutical Co., LTD a buy, hold, or sell?
MoatMap’s current signal for Jiangsu Nhwa Pharmaceutical Co., LTD (002262.SZ) is Buy, based on a StockRank of 78/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Jiangsu Nhwa Pharmaceutical Co., LTD in?
Jiangsu Nhwa Pharmaceutical Co., LTD (002262.SZ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).
Browse all ranked stocks002262.SZ deep dive reportAI ChampionsHow we score stocksSense-check another stock